News and Topics
Featured News
Public engagement is key to building momentum for longevity science, and you can make a real difference. Our nonprofit team works hard to bring you the latest news in the field, based on a clear code of journalistic ethics. Please consider making a donation to support our work. Thank You.
A recent study showed that a treatment with the short peptide elamipretide reversed multiple signs of age-related decline in oocyte quality in
A new study shows healthspan and lifespan increases in male mice following late-life treatment with vanadyl sulfate, a food-derived molecule marketed as
After a review of substantial literature, scientists publishing in Aging Cell have concluded that poor sleep quality and inflammaging worsen each other
In a clinical trial, the supplement NOVOS Core was associated with significant improvements in artery function and systolic blood pressure. It is
This month has been marked by progress in both the regulatory and investment sides of rejuvenation biotechnology. For years, the field has
A new study found that shrinking reserves of naive T cells weaken tumor recognition in male mice by middle age more than
As the weather cools down, the race for functional interventions heats up, and members of our field have been looking for ways
In a new study, late-life treatment with a three-element senolytic vaccine led to lower senescence markers and a 12% increase in median
In Aging Cell, researchers have described how increasing fibroblast growth factor 13 (FGF13) in astrocytes reduces aging throughout the bodies of mice.
A recent study identified SRSF1, an RNA-processing and splicing factor, as a molecule with geroprotective potential. Inducing SRSF1 expression rejuvenated human cells
One of the oldest and biggest longevity conferences moved this year across the Atlantic, from Copenhagen to Boston. The new location brought
Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, announced interim data from its Phase
- Advocacy, arp, FDA, Policy, Regulations
Researchers are developing biomedical repair therapies to address multiple age-related diseases at once, yet they are forced to put them through regulatory
Laura Minquini is not a scientist, but that hasn’t stopped her from joining the front lines of the war on aging: specifically,
A team of researchers has written a paper with a surprising finding: that many of the benefits of caloric restriction and increased